Academic Staff

Assoc. Prof. Dr. Busba Chindavijak Assoc. Prof. Dr. Busba Chindavijak busba.chi@mahidol.ac.th busba.chi@mahidol.ac.th Department of Pharmacy, Faculty of Pharmacy, Mahidol University.

2021

1. Educational program to improve hypertension knowledge by a community pharmacist in a rural district in Indonesia

   Wulandari UA, Kristina SA, Chindavijak B, Chulavatnatol S, Nathisuwan S*. JACCP journal of the american college of clinical pharmacy 2021; 4(6): 711-717.
   
   

2. Guideline concordance of bisphosphonates used for osteoporosis in a university hospital, Thailand

   Anusathitwattana S, Sa-ngasoongsong P, Montakantikul P, Lekpittaya N, Chindavijak B*. Pharmaceutical sciences asia 2021; 48(1): 52-60.
   
   

3. Therapeutic drug monitoring of intravenous busulfan in Thai children undergoing hematopoietic stem cell transplantation: A pilot study

   Jansing T, Sanpakit K*, Tharnpanich T, Jiranantakan T, Niphandwongkorn V, Chindavijak B , Suansanae T. Pediatr hematol oncol 2021; 38(4): 346-357.
   
   

2020

1. Microbial epidemiology and risk factors for relapse in gram-negative bacteria catheter-related bloodstream infection with a pilot prospective study in patients with catheter removal receiving short-duration of antibiotic therapy

   Surapat B, Montakantikul P, Malathum K, Kiertiburanakul S, Santanirand P, Chindavijak B*. BMC infectious diseases 2020; 2(1): 604.
   
   

2. Relationship of anemia and clinical outcome in heart failure patients with preserved versus reduced ejection fraction in a rural area of Thailand

   Chairat K, Rattanavipanon W, Tanyasaensook K, Chindavijak B, Chulavatnatol S, Nathisuwan S*. Int J cardiol heart vasc 2020; 30: 100597.
   
   

3. The association between trough blood concentration and systemic exposure of tacrolimus: Comparison between once-daily (Advagraf®) and twice-daily (Prograf®) formulation in de novo kidney transplant recipients.

   Sukkha S, Chindavijak B, Nosoongnoen W, Phakdeekitchareon B, Kitiyakara C, Sumethkul V*. Drug metab pharmacokinet 2020; 35(1): 139-144.
   
   

2019

1. Optimization of intermittent vancomycin dosage regimens for Thai Critically Ill Population Infected by MRSA in the Era of the "MIC Creep" Phenomenon

   Setiawan E, Suwannoi L, Montakantikul P, Chindavijak B. ACTA MEDICA INDONESIANA 2019;51(1):10-18
   
   

2018

1. Comparative performance of pharmacogenetics-based warfarin dosing algorithms derived from caucasian, asian, and mixed races in Thai population

   Chumnumwat S, Yi K, Lucksiri A, Nosoongnoen W, Chindavijak B, Chulavatnatol S, Sarapakdi A, Nathisuwan S*. Cardiovascular Therapeutics 2018; 36(2): e12315
   
   

2017

1. Trough level from twice daily to once daily tacrolimus in early conversion kidney transplant recipients: a prospective study

   Sukkha S, Chindavijak B, Montakantikul P, Ingsathit A, Nosoongnoen W*, Sumethkul V. International Journal of Clinical Pharmacy. 2017; 39(6): 1298-1303.
   
   

2016

1. Implementation of a nutrition program reduced post-discharge growth restriction in Thai very low birth weight preterm infants

   Japakasetr S, Sirikulchayanonta C*, Suthutvoravut U, Chindavijak B, Kagawa M, Nokdee S. Nutrients 2016; 8(12)
   
   

2015

1. Prescribing patterns and evaluation of appropriateness of combination of cox-2 inhibitors and proton pump inhibitors for pain management.

   Suansanae T, Jenphotjanasunthorn S, Phanthong P, Peradhamanon P, Chindavijak B. International Journal of Clincal Pharmacy 2015; 37(1): 260-261.
   
   

2014

1. Adverse Drug Event of Hospitalized Patients from Multi-Hospitals in Thailand

   Tragulpiankit P, Yeesoonpan N, Ninsananda T, Chindavijak B, Chulavatnatol S, Chaikledkaew U, Uaviseswong T. Pharmacoepidemiology and drug safety 2014; 23: 289-289
   
   

2013

1. Nutrition Screening Tools and Prediction of Malnutrition Incidence in Major Abdominal Surgery Patients at a Tertiary

   Permsombut N, Chindavijak B*, Teawprasert P. Mahidol University Journal of Pharmaceutical Sciences 2013; 40 (3), 26-34 2013; 40 (3), 26-34
   
   

2. Study of Oxaliplatin-based Chemotherapy-Induced Neurotoxicity in Colorectal Cancer Thai Patients

   Wutthikonsammakit J, Chindavijak B*, Chaikredkaew U, Lausoontornsiri W. Mahidol University Journal of Pharmaceutical Sciences 2013; 40 (4), 8-16
   
   

3. The Study of Medication Compliance of Sick Priests at Outpatient Department of Priest Hospital

   Suansanae T, Chotewirut N, Tanchaloemchai S, Peradhamanon P, Chindavijak B. วารสารเภสัชกรรมโรงพยาบาล 2013;23(2):86-93
   
   

2012

1. Population pharmacokinetics of vancomycin in Thai patients

   Purwonugroho TA, Chulavatnatol S*, Preechagoon Y, Chindavijak B, Malathum K, Bunuparadah P. The Scientific World Journal 2012; 2012
   
   

2009

1. Effects of changes in patients’ nutritional status upon complications, clinical outcomes, length of hospital stay and hospital expense

   Chindavijak B, KomindrS, Ritsri W , Montakantikul P. Thai Journal of Clinical Nutrition 2009; 3(2): 81-5.
   
   

2. In vitro interactions between cotrimoxazole and doxycycline in Burkholderia pseudomallei: How important is this combination in maintenance therapy of melioidosis?

   Saraya S, Soontornpas C, Chindavijak B, Mootsikapun P*. Indian J Med Microbiol 2009; 27: 88-9.
   
   

2007

1. Comparison of essential trace elements in blood of patients receiving Ramathibodi standard parenteral nutrition with ramatrace or a commercial formular.

   Roongpisuthipong C*, Chiaovit J, Songchitsomboon S, Chindavijak B. J Med Assoc Thailand 2007; 90(1) Jan: 37-44.
   
   

2. Effect of four commercial amino acid solutions on solubility of calcium and phosphate in pediatric parenteral nutrition solutions.

   Wongpanich Y, Chindavijak B, Lawanprasert P. Thai J Parenter Enteral Nutr 2007; 18: 23-31.
   
   

3. Impact of a new guideline for central venous catheter care on sepsis in total parenteral nutrition: Experience in Ramathibodi hospital

   Roongpisuthipong C*, Getupook V, Chindavijak B. Journal of the Medical Association of Thailand. 2007; 90(10) Oct: 2030-2038.
   
   

2005

1. Time-kill curves as a tool for targeting ceftazidime serum concentration during continuous infusion for treatment of septicaemic melioidosis.

   Mootsikapun P, Soontornpas C*, Saraya S, Chulasiri M, Chindavijak B. Int J Antimicrob Ag 2005; 26(5): 403-407.
   
   

2003

1. Percutaneous absorption enhancement of acyclovir

   Lawanprasert P, Auychaipornlert S, Thisuphakorn P, Sarisuta N, Chindavijak B Mahidol J Pharm Sci 2003;30(3): 17-24
   
   

2. Pharmacokinetics of ofloxacin in drug-resistant tuberculosis.

   Chulavatnatol S*, Chindavijak B, Chierakul N, Klomsawat D. J Med Assoc Thailand 2003; 86:781-8
   
   

2001

1. Conversion from intravenous route to oral route of antimicrobial therapy.

   Norwavan P, Chindavijak B, Vibhagool A. J Infect Dis Antimicrob Agents 2001; 18: 63-70.
   
   

2. Intrapulmonary pharmacokinetics of ofloxacin in drug-resistant tuberculosis.

   Chierakul N, Klomsawat D, Chulavatnatol S, Chindavijak B. Int J Tuberc Lung Dis 2001; 5(3): 278-82
   
   

1999

1. Pharmacokinetics of levofloxacin in healthy Thai male volunteers.

   Chulavatnatol S, Chindavijak B, Vibhagool A, Wananukul W, Sriapha C, Sirisangtragul C. J Med Assoc Thailand 1999; 82 (11): 1127-35
   
   

1998

1. Noncompliance of antihypertensive drugs used among out-patients at Surat-thani.Hospital.

   Chindavijak B, Punyawantani W, Chansirikarn S. Bulletin Assoc Hosp Pharmacy (Thailand) 1998; 8:1-9
   
   

1996

1. Betacarotene serum profile after single dose adminstration of betacarotene capsule v.s. carrot.

   Chindavijak B, Sornsuvit C, Vajragupta O, Pattamakom V. Thai J Phytopharm 1996; 3:7-15
   
   

2. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/ hemoglobin E disease.

   Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schecter AN and Rodgers GP. Blood 1996; 87:887-92
   
   

3. In-patient adverse drug reaction monitoring at the Department of Medicine, Ramathibodi Hospital.

   Chindavijak B, Tragulpiankit P, Kaojarern S, Pummangura C. Ramathibodi Med J 1996, 19: 17-25.
   
   

1995

1. 24 hour serum level after a single dose administration of beta-carotene capsule.

   Chindavijak B, Soontornpass C, Vajragupta O Mahidol J Pharm Sci 1995; 22:92-100
   
   

1994

1. Pharmacokinetics of hydroxyurea in Thai patients with beta thalassemia/HbE disease.

   Chindavijak B, Poolsup N, Saraya S, Fucharoen S. Thai J Hemato Trans Med 1994;4 (4):19-24
   
   

1992

1. Incompatibility of calcium phosphate in parenteral nutrition solution.

   Chindavijak B, Suthatvoravut U, Winitwatjana W, Sriurairatana S. Thai JPEN 1992; 3: 2-10.
   
   

1988

1. Alteration of the pharmacokinetics and metabolism of propranolol and antipyrine elicited by indwelling catheters in the rat.

   Chindavijak B, Belpaire FM, De Smet F, Bogaert MG J Pharmacol Exp Ther 1988; 246: 1075-9.
   
   

2. Effect of inflammation on the metabolism of antipyrine, lidocaine and propranolol in isolated rat hepatocytes.

   Chindavijak B, Belpaire FM, Bogaert MG. Pharmacology 1988; 36: 279-82.
   
   

1987

1. Effect of inflammation and proadifen on the disposition of antipyrine, lignocaine and propranolol in rat isolated perfused liver.

   Chindavijak B, Belpaire FM, Bogaert MG. J Pharm Pharmacol 1987; 39: 997-1002.
   
   

2. Effect of inflammation on the metabolism of antipyrine, lidocaine and propranolol in isolated rat hepatocytes.

   Chindavijak B, Belpaire FM, Bogaert MG. Arch Int Pharmacodyn 1987; 290: 152.
   
   

3. In-vitro biotransformation of antipyrine, lignocaine and propranolol in the liver of rats with turpentine-induced inflammation.

   Chindavijak B, Belpaire FM, Bogaert MG. J Pharm Pharmacol 1987; 39: 883-6.
   
   

4. SKF 525 A displaces drugs from serum alpha1- acid glycoprotein binding sites.

   Belpaire FM, Chindavijak B, Bogaert MG. J Pharmacol Exp Ther 1987; 240: 628-30.
   
   

1986

1. Displacement of drugs from serum alpha1- acid glycoprotein binding sites by SKF 525 A.

   Belpaire FM, Bogaert MG, Chindavijak B. Brit J Pharmacol 1986; 89: 479P.
   
   

2. Effect of inflammation on the disposition of propranolol, lidocaine and antipyrine in the isolated perfused rat liver.

   Chindavijak B, Belpaire FM, Bogaert MG. Arch Int Pharmacodyn 1986; 281: 332.
   
   

1985

1. Effect of inflammation on the disposition of propranolol and antipyrine in the isolated perfused rat liver.

   Chindavijak B, Belpaire FM, Bogaert MG. Naunyn-Schmiedeberg"s Arch Pharmacol 1985; 330: R12.
   
   

1982

1. Incompatibility of 8 commonly additives in IV admixture used in Thailand.

   Chindavijak B, Pummangura C. Thai Pharm J 1982; 7: 8-234.
   
   

---

หมายเหตุ: ชื่อที่ใช้ในการทำวิจัยของ Assoc. Prof. Dr. Busba Chindavijak ได้แก่ บุษบา จินดาวิจักษณ์ ; Chindavijak B ;